Table 1 Baseline characteristics of the study population
Parameters | HIV POSITIVE | HIV NEGATIVE | TOTAL |
|---|---|---|---|
n (%) | n (%) | n (%) | |
Age groups (years) | |||
  ≤ 25 | 11 (3.6) | 48 (47.1) | 59 (14.4) |
 26–40 | 156 (50.5) | 35 (34.3) | 191 (46.5) |
  > 40 | 142 (46.0) | 19 (18.6) | 161 (39.2) |
Sex | |||
 Female | 238 (77.0) | 61 (59.8) | 299 (72.7) |
 Male | 71 (23.0) | 41 (40.2) | 112 (27.3) |
Educational Level | |||
 No formal | 30 (9.7) | 3 (3.4) | 33 (8.3) |
 Primary | 135 (43.7) | 22 (25.0) | 157 (39.5) |
 Secondary | 124 (40.1) | 45 (51.1) | 169 (42.6) |
 Tertiary | 20 (6.5) | 18 (20.5) | 38 (9.6) |
ITN usage | 196 (63.4) | 53 (52.0) | 249 (60.6) |
IRS usage | 78 (25.2) | 26 (25.5) | 104 (25.3) |
Clinical | |||
CD4 T-cell count(cells/μl) | |||
  < 200 | 41 (23.7) |  | 41 (23.7) |
 200–499 | 71 (41.0) |  | 71 (41.0) |
  > 500 | 61 (35.3) |  | 61 (35.3) |
ART usage | 292 (94.5) | Â | 292 (94.5) |
ART Duration (months) | |||
  < 12 | 33 (10.8) |  | 33 (10.8) |
 12–35 | 82 (26.8) |  | 82 (26.8) |
  ≥ 36 | 191 (61.8) |  | 191 (61.8) |
Fever prevalence | 16 (5.2) | 18 (17.6) | 34 (8.3) |
Malaria prevalence | 24 (7.8) | 34 (33.3) | 58 (14.1) |
Anaemia prevalence | 173 (56.0) | 41 (40.2) | 214 (52.1) |
Anaemia severity | |||
 Mild | 95 (54.9) | 16 (39) | 111 (51.9) |
 Moderate | 69 (39.9) | 22 (53.7) | 91 (42.5) |
 Severe | 9 (5.2) | 3 (7.3) | 12 (5.6) |